averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
STAT6
|
ENSG00000166888.6 | signal transducer and activator of transcription 6 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
STAT6 | hg19_v2_chr12_-_57505121_57505216 | 0.28 | 3.5e-05 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr16_+_30075463 | 13.49 |
ENST00000562168.1
ENST00000569545.1 |
ALDOA
|
aldolase A, fructose-bisphosphate |
chr16_+_30075595 | 13.14 |
ENST00000563060.2
|
ALDOA
|
aldolase A, fructose-bisphosphate |
chr16_+_30075783 | 12.44 |
ENST00000412304.2
|
ALDOA
|
aldolase A, fructose-bisphosphate |
chr14_-_69446034 | 12.40 |
ENST00000193403.6
|
ACTN1
|
actinin, alpha 1 |
chr11_-_14379997 | 11.32 |
ENST00000526063.1
ENST00000532814.1 |
RRAS2
|
related RAS viral (r-ras) oncogene homolog 2 |
chr5_+_102201722 | 9.94 |
ENST00000274392.9
ENST00000455264.2 |
PAM
|
peptidylglycine alpha-amidating monooxygenase |
chr1_-_68299130 | 9.69 |
ENST00000370982.3
|
GNG12
|
guanine nucleotide binding protein (G protein), gamma 12 |
chr5_+_74011328 | 7.59 |
ENST00000513336.1
|
HEXB
|
hexosaminidase B (beta polypeptide) |
chr1_-_209824643 | 6.27 |
ENST00000391911.1
ENST00000415782.1 |
LAMB3
|
laminin, beta 3 |
chr1_-_108735440 | 5.90 |
ENST00000370041.4
|
SLC25A24
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 24 |
chrX_+_135251783 | 5.84 |
ENST00000394153.2
|
FHL1
|
four and a half LIM domains 1 |
chr12_-_6451235 | 5.62 |
ENST00000440083.2
ENST00000162749.2 |
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A |
chr17_-_39681578 | 5.59 |
ENST00000593096.1
|
KRT19
|
keratin 19 |
chr6_+_32821924 | 5.49 |
ENST00000374859.2
ENST00000453265.2 |
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9 |
chr3_+_158787041 | 5.39 |
ENST00000471575.1
ENST00000476809.1 ENST00000485419.1 |
IQCJ-SCHIP1
|
IQCJ-SCHIP1 readthrough |
chr5_+_118691706 | 5.35 |
ENST00000415806.2
|
TNFAIP8
|
tumor necrosis factor, alpha-induced protein 8 |
chr22_+_44464923 | 5.12 |
ENST00000404989.1
|
PARVB
|
parvin, beta |
chr21_+_42539701 | 5.02 |
ENST00000330333.6
ENST00000328735.6 ENST00000347667.5 |
BACE2
|
beta-site APP-cleaving enzyme 2 |
chr2_-_190044480 | 4.96 |
ENST00000374866.3
|
COL5A2
|
collagen, type V, alpha 2 |
chr8_+_97506033 | 4.77 |
ENST00000518385.1
|
SDC2
|
syndecan 2 |
chr3_+_158991025 | 4.66 |
ENST00000337808.6
|
IQCJ-SCHIP1
|
IQCJ-SCHIP1 readthrough |
chrX_+_135251835 | 4.64 |
ENST00000456445.1
|
FHL1
|
four and a half LIM domains 1 |
chr17_+_34640031 | 4.55 |
ENST00000339270.6
ENST00000482104.1 |
CCL4L2
|
chemokine (C-C motif) ligand 4-like 2 |
chr17_+_34538310 | 4.53 |
ENST00000444414.1
ENST00000378350.4 ENST00000389068.5 ENST00000588929.1 ENST00000589079.1 ENST00000589336.1 ENST00000400702.4 ENST00000591167.1 ENST00000586598.1 ENST00000591637.1 ENST00000378352.4 ENST00000358756.5 |
CCL4L1
|
chemokine (C-C motif) ligand 4-like 1 |
chr2_+_120124497 | 4.52 |
ENST00000355857.3
ENST00000535617.1 ENST00000535757.1 ENST00000409094.1 ENST00000311521.4 |
DBI
|
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) |
chr8_+_9953214 | 4.40 |
ENST00000382490.5
|
MSRA
|
methionine sulfoxide reductase A |
chr8_+_9953061 | 4.37 |
ENST00000522907.1
ENST00000528246.1 |
MSRA
|
methionine sulfoxide reductase A |
chr15_+_89402148 | 4.32 |
ENST00000560601.1
|
ACAN
|
aggrecan |
chrX_+_135252050 | 4.32 |
ENST00000449474.1
ENST00000345434.3 |
FHL1
|
four and a half LIM domains 1 |
chr6_-_24877490 | 4.22 |
ENST00000540914.1
ENST00000378023.4 |
FAM65B
|
family with sequence similarity 65, member B |
chr14_+_56127989 | 4.18 |
ENST00000555573.1
|
KTN1
|
kinectin 1 (kinesin receptor) |
chr1_-_241803679 | 4.10 |
ENST00000331838.5
|
OPN3
|
opsin 3 |
chrX_+_100878079 | 4.05 |
ENST00000471229.2
|
ARMCX3
|
armadillo repeat containing, X-linked 3 |
chr3_-_185655795 | 3.85 |
ENST00000342294.4
ENST00000382191.4 ENST00000453386.2 |
TRA2B
|
transformer 2 beta homolog (Drosophila) |
chr15_+_96869165 | 3.85 |
ENST00000421109.2
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
chr6_-_11232891 | 3.74 |
ENST00000379433.5
ENST00000379446.5 |
NEDD9
|
neural precursor cell expressed, developmentally down-regulated 9 |
chr17_+_34639793 | 3.64 |
ENST00000394465.2
ENST00000394463.2 ENST00000378342.4 |
CCL4L2
|
chemokine (C-C motif) ligand 4-like 2 |
chr1_+_89246647 | 3.59 |
ENST00000544045.1
|
PKN2
|
protein kinase N2 |
chr7_-_76829125 | 3.46 |
ENST00000248598.5
|
FGL2
|
fibrinogen-like 2 |
chr11_-_10828892 | 3.29 |
ENST00000525681.1
|
EIF4G2
|
eukaryotic translation initiation factor 4 gamma, 2 |
chr8_+_104311059 | 3.27 |
ENST00000358755.4
ENST00000523739.1 ENST00000540287.1 |
FZD6
|
frizzled family receptor 6 |
chr2_-_230786619 | 3.26 |
ENST00000389045.3
ENST00000409677.1 |
TRIP12
|
thyroid hormone receptor interactor 12 |
chr14_-_23285011 | 3.26 |
ENST00000397532.3
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr10_-_65028817 | 3.23 |
ENST00000542921.1
|
JMJD1C
|
jumonji domain containing 1C |
chr11_+_118230287 | 3.23 |
ENST00000252108.3
ENST00000431736.2 |
UBE4A
|
ubiquitination factor E4A |
chr9_+_36572851 | 3.21 |
ENST00000298048.2
ENST00000538311.1 ENST00000536987.1 ENST00000545008.1 ENST00000536860.1 ENST00000536329.1 ENST00000541717.1 ENST00000543751.1 |
MELK
|
maternal embryonic leucine zipper kinase |
chr12_+_56435637 | 3.17 |
ENST00000356464.5
ENST00000552361.1 |
RPS26
|
ribosomal protein S26 |
chr6_-_32821599 | 3.17 |
ENST00000354258.4
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
chr12_-_111358372 | 3.17 |
ENST00000548438.1
ENST00000228841.8 |
MYL2
|
myosin, light chain 2, regulatory, cardiac, slow |
chrX_-_106960285 | 3.11 |
ENST00000503515.1
ENST00000372397.2 |
TSC22D3
|
TSC22 domain family, member 3 |
chr14_-_23285069 | 2.99 |
ENST00000554758.1
ENST00000397528.4 |
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr20_-_23066953 | 2.97 |
ENST00000246006.4
|
CD93
|
CD93 molecule |
chr4_-_120988229 | 2.97 |
ENST00000296509.6
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast) |
chr1_+_114472481 | 2.94 |
ENST00000369555.2
|
HIPK1
|
homeodomain interacting protein kinase 1 |
chr1_+_114472222 | 2.75 |
ENST00000369558.1
ENST00000369561.4 |
HIPK1
|
homeodomain interacting protein kinase 1 |
chr17_+_7462103 | 2.75 |
ENST00000396545.4
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13 |
chr5_+_140602904 | 2.66 |
ENST00000515856.2
ENST00000239449.4 |
PCDHB14
|
protocadherin beta 14 |
chr11_-_60719213 | 2.60 |
ENST00000227880.3
|
SLC15A3
|
solute carrier family 15 (oligopeptide transporter), member 3 |
chr3_-_49851313 | 2.58 |
ENST00000333486.3
|
UBA7
|
ubiquitin-like modifier activating enzyme 7 |
chr8_+_11666649 | 2.50 |
ENST00000528643.1
ENST00000525777.1 |
FDFT1
|
farnesyl-diphosphate farnesyltransferase 1 |
chr17_-_34207295 | 2.43 |
ENST00000463941.1
ENST00000293272.3 |
CCL5
|
chemokine (C-C motif) ligand 5 |
chr2_+_182756615 | 2.43 |
ENST00000431877.2
ENST00000320370.7 |
SSFA2
|
sperm specific antigen 2 |
chr17_+_34431212 | 2.36 |
ENST00000394495.1
|
CCL4
|
chemokine (C-C motif) ligand 4 |
chr8_-_117886955 | 2.28 |
ENST00000297338.2
|
RAD21
|
RAD21 homolog (S. pombe) |
chr17_+_7462031 | 2.20 |
ENST00000380535.4
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13 |
chr12_+_123949053 | 2.15 |
ENST00000350887.5
|
SNRNP35
|
small nuclear ribonucleoprotein 35kDa (U11/U12) |
chr7_-_38305279 | 2.03 |
ENST00000443402.2
|
TRGC1
|
T cell receptor gamma constant 1 |
chr14_-_25103388 | 2.03 |
ENST00000526004.1
ENST00000415355.3 |
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
chr3_+_179370517 | 2.02 |
ENST00000263966.3
|
USP13
|
ubiquitin specific peptidase 13 (isopeptidase T-3) |
chr1_-_241683001 | 1.97 |
ENST00000366560.3
|
FH
|
fumarate hydratase |
chr1_-_120935894 | 1.96 |
ENST00000369383.4
ENST00000369384.4 |
FCGR1B
|
Fc fragment of IgG, high affinity Ib, receptor (CD64) |
chr16_-_73093597 | 1.95 |
ENST00000397992.5
|
ZFHX3
|
zinc finger homeobox 3 |
chr17_+_68071389 | 1.94 |
ENST00000283936.1
ENST00000392671.1 |
KCNJ16
|
potassium inwardly-rectifying channel, subfamily J, member 16 |
chr1_+_149754227 | 1.90 |
ENST00000444948.1
ENST00000369168.4 |
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64) |
chr2_+_68961905 | 1.87 |
ENST00000295381.3
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr5_+_35856951 | 1.86 |
ENST00000303115.3
ENST00000343305.4 ENST00000506850.1 ENST00000511982.1 |
IL7R
|
interleukin 7 receptor |
chr12_+_12764773 | 1.86 |
ENST00000228865.2
|
CREBL2
|
cAMP responsive element binding protein-like 2 |
chr11_+_112832133 | 1.82 |
ENST00000524665.1
|
NCAM1
|
neural cell adhesion molecule 1 |
chr2_+_68961934 | 1.79 |
ENST00000409202.3
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr11_-_67980744 | 1.79 |
ENST00000401547.2
ENST00000453170.1 ENST00000304363.4 |
SUV420H1
|
suppressor of variegation 4-20 homolog 1 (Drosophila) |
chr9_+_90112117 | 1.75 |
ENST00000358077.5
|
DAPK1
|
death-associated protein kinase 1 |
chr22_-_42342692 | 1.74 |
ENST00000404067.1
ENST00000402338.1 |
CENPM
|
centromere protein M |
chr18_-_24445664 | 1.74 |
ENST00000578776.1
|
AQP4
|
aquaporin 4 |
chr6_+_26440700 | 1.72 |
ENST00000494393.1
ENST00000482451.1 ENST00000244519.2 ENST00000339789.4 ENST00000471353.1 ENST00000361232.3 ENST00000487627.1 ENST00000496719.1 ENST00000490254.1 ENST00000487272.1 |
BTN3A3
|
butyrophilin, subfamily 3, member A3 |
chr5_+_138609441 | 1.68 |
ENST00000509990.1
ENST00000506147.1 ENST00000512107.1 |
MATR3
|
matrin 3 |
chr17_+_7461613 | 1.65 |
ENST00000438470.1
ENST00000436057.1 |
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13 |
chr17_+_7461781 | 1.60 |
ENST00000349228.4
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13 |
chr17_+_7461849 | 1.50 |
ENST00000338784.4
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13 |
chr8_+_123793633 | 1.49 |
ENST00000314393.4
|
ZHX2
|
zinc fingers and homeoboxes 2 |
chr17_+_7461580 | 1.48 |
ENST00000483039.1
ENST00000396542.1 |
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13 |
chr2_-_133427767 | 1.47 |
ENST00000397463.2
|
LYPD1
|
LY6/PLAUR domain containing 1 |
chr22_-_42343117 | 1.47 |
ENST00000407253.3
ENST00000215980.5 |
CENPM
|
centromere protein M |
chr14_-_25103472 | 1.46 |
ENST00000216341.4
ENST00000382542.1 ENST00000382540.1 |
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
chr14_-_25078864 | 1.33 |
ENST00000216338.4
ENST00000557220.2 ENST00000382548.4 |
GZMH
|
granzyme H (cathepsin G-like 2, protein h-CCPX) |
chr10_+_115674530 | 1.33 |
ENST00000451472.1
|
AL162407.1
|
CDNA FLJ20147 fis, clone COL07954; HCG1781466; Uncharacterized protein |
chr15_+_25200074 | 1.32 |
ENST00000390687.4
ENST00000584968.1 ENST00000346403.6 ENST00000554227.2 |
SNRPN
|
small nuclear ribonucleoprotein polypeptide N |
chr11_+_65101225 | 1.29 |
ENST00000528416.1
ENST00000415073.2 ENST00000252268.4 |
DPF2
|
D4, zinc and double PHD fingers family 2 |
chr15_+_25200108 | 1.29 |
ENST00000577949.1
ENST00000338094.6 ENST00000338327.4 ENST00000579070.1 ENST00000577565.1 |
SNURF
SNRPN
|
SNRPN upstream reading frame protein small nuclear ribonucleoprotein polypeptide N |
chr9_+_90112741 | 1.29 |
ENST00000469640.2
|
DAPK1
|
death-associated protein kinase 1 |
chr22_-_31364187 | 1.23 |
ENST00000215862.4
ENST00000397641.3 |
MORC2
|
MORC family CW-type zinc finger 2 |
chr2_-_16804320 | 1.20 |
ENST00000355549.2
|
FAM49A
|
family with sequence similarity 49, member A |
chr7_-_150777949 | 1.18 |
ENST00000482571.1
|
FASTK
|
Fas-activated serine/threonine kinase |
chr1_-_147245445 | 1.17 |
ENST00000430508.1
|
GJA5
|
gap junction protein, alpha 5, 40kDa |
chr4_-_110723134 | 1.11 |
ENST00000510800.1
ENST00000512148.1 |
CFI
|
complement factor I |
chr7_-_150777920 | 1.11 |
ENST00000353841.2
ENST00000297532.6 |
FASTK
|
Fas-activated serine/threonine kinase |
chr1_+_150245099 | 1.06 |
ENST00000369099.3
|
C1orf54
|
chromosome 1 open reading frame 54 |
chr12_+_6493199 | 1.06 |
ENST00000228918.4
|
LTBR
|
lymphotoxin beta receptor (TNFR superfamily, member 3) |
chr2_+_27440229 | 0.95 |
ENST00000264705.4
ENST00000403525.1 |
CAD
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase |
chr15_+_64386261 | 0.93 |
ENST00000560829.1
|
SNX1
|
sorting nexin 1 |
chr9_+_90112767 | 0.92 |
ENST00000408954.3
|
DAPK1
|
death-associated protein kinase 1 |
chr4_+_30721968 | 0.82 |
ENST00000361762.2
|
PCDH7
|
protocadherin 7 |
chr19_+_38924316 | 0.81 |
ENST00000355481.4
ENST00000360985.3 ENST00000359596.3 |
RYR1
|
ryanodine receptor 1 (skeletal) |
chr7_-_150777874 | 0.77 |
ENST00000540185.1
|
FASTK
|
Fas-activated serine/threonine kinase |
chr14_+_38677123 | 0.76 |
ENST00000267377.2
|
SSTR1
|
somatostatin receptor 1 |
chr3_-_57233966 | 0.75 |
ENST00000473921.1
ENST00000295934.3 |
HESX1
|
HESX homeobox 1 |
chr9_+_90112590 | 0.74 |
ENST00000472284.1
|
DAPK1
|
death-associated protein kinase 1 |
chr2_+_191792376 | 0.73 |
ENST00000409428.1
ENST00000409215.1 |
GLS
|
glutaminase |
chr1_-_116383322 | 0.71 |
ENST00000429731.1
|
NHLH2
|
nescient helix loop helix 2 |
chr11_-_72463421 | 0.63 |
ENST00000393609.3
|
ARAP1
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
chr1_+_12123414 | 0.63 |
ENST00000263932.2
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8 |
chr1_-_94586651 | 0.53 |
ENST00000535735.1
ENST00000370225.3 |
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4 |
chr5_-_88119580 | 0.51 |
ENST00000539796.1
|
MEF2C
|
myocyte enhancer factor 2C |
chr1_+_32608566 | 0.48 |
ENST00000545542.1
|
KPNA6
|
karyopherin alpha 6 (importin alpha 7) |
chr12_-_71031185 | 0.47 |
ENST00000548122.1
ENST00000551525.1 ENST00000550358.1 |
PTPRB
|
protein tyrosine phosphatase, receptor type, B |
chr17_-_17740287 | 0.39 |
ENST00000355815.4
ENST00000261646.5 |
SREBF1
|
sterol regulatory element binding transcription factor 1 |
chr11_-_128457446 | 0.38 |
ENST00000392668.4
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
chr5_+_102201687 | 0.37 |
ENST00000304400.7
|
PAM
|
peptidylglycine alpha-amidating monooxygenase |
chr7_-_122840015 | 0.34 |
ENST00000194130.2
|
SLC13A1
|
solute carrier family 13 (sodium/sulfate symporter), member 1 |
chr4_-_186877806 | 0.34 |
ENST00000355634.5
|
SORBS2
|
sorbin and SH3 domain containing 2 |
chr3_-_120365866 | 0.33 |
ENST00000475447.2
|
HGD
|
homogentisate 1,2-dioxygenase |
chr3_+_63898275 | 0.33 |
ENST00000538065.1
|
ATXN7
|
ataxin 7 |
chr11_+_7618413 | 0.29 |
ENST00000528883.1
|
PPFIBP2
|
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
chr4_-_46391931 | 0.29 |
ENST00000381620.4
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2 |
chr7_+_55433131 | 0.29 |
ENST00000254770.2
|
LANCL2
|
LanC lantibiotic synthetase component C-like 2 (bacterial) |
chr3_+_51575596 | 0.25 |
ENST00000409535.2
|
RAD54L2
|
RAD54-like 2 (S. cerevisiae) |
chr2_+_234526272 | 0.24 |
ENST00000373450.4
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A8 |
chr19_+_2785458 | 0.21 |
ENST00000307741.6
ENST00000585338.1 |
THOP1
|
thimet oligopeptidase 1 |
chr6_-_41254403 | 0.21 |
ENST00000589614.1
ENST00000334475.6 ENST00000591620.1 ENST00000244709.4 |
TREM1
|
triggering receptor expressed on myeloid cells 1 |
chr1_-_190446759 | 0.19 |
ENST00000367462.3
|
BRINP3
|
bone morphogenetic protein/retinoic acid inducible neural-specific 3 |
chr4_+_71337834 | 0.18 |
ENST00000304887.5
|
MUC7
|
mucin 7, secreted |
chr12_+_15125954 | 0.17 |
ENST00000266395.2
|
PDE6H
|
phosphodiesterase 6H, cGMP-specific, cone, gamma |
chr9_-_13175823 | 0.15 |
ENST00000545857.1
|
MPDZ
|
multiple PDZ domain protein |
chr11_+_65082289 | 0.11 |
ENST00000279249.2
|
CDC42EP2
|
CDC42 effector protein (Rho GTPase binding) 2 |
chr7_+_138818490 | 0.09 |
ENST00000430935.1
ENST00000495038.1 ENST00000474035.2 ENST00000478836.2 ENST00000464848.1 ENST00000343187.4 |
TTC26
|
tetratricopeptide repeat domain 26 |
chr13_+_73629107 | 0.07 |
ENST00000539231.1
|
KLF5
|
Kruppel-like factor 5 (intestinal) |
chr10_-_35379524 | 0.05 |
ENST00000374751.3
ENST00000374742.1 ENST00000602371.1 |
CUL2
|
cullin 2 |
chr14_+_22520762 | 0.04 |
ENST00000390449.3
|
TRAV21
|
T cell receptor alpha variable 21 |
chr1_-_116383738 | 0.03 |
ENST00000320238.3
|
NHLH2
|
nescient helix loop helix 2 |
chr4_-_46391805 | 0.02 |
ENST00000540012.1
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 10.3 | GO:0031179 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
2.2 | 39.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
1.5 | 7.6 | GO:0007619 | courtship behavior(GO:0007619) |
1.2 | 5.0 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
1.0 | 6.2 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) basic amino acid transmembrane transport(GO:1990822) |
1.0 | 8.8 | GO:0030091 | protein repair(GO:0030091) |
1.0 | 3.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.0 | 3.8 | GO:0009956 | radial pattern formation(GO:0009956) |
0.9 | 11.2 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.8 | 3.3 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.8 | 3.2 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.8 | 12.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.7 | 5.9 | GO:0015866 | ADP transport(GO:0015866) |
0.7 | 5.1 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.7 | 4.8 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.7 | 4.8 | GO:0008218 | bioluminescence(GO:0008218) |
0.7 | 2.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.6 | 5.7 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.6 | 5.0 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.5 | 5.6 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.5 | 2.0 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.5 | 2.5 | GO:0008204 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.5 | 3.5 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.5 | 1.9 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.5 | 3.3 | GO:1901314 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
0.4 | 3.2 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.4 | 3.1 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.4 | 2.3 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.3 | 3.0 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.3 | 2.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.3 | 0.9 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
0.3 | 4.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.3 | 4.7 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.3 | 4.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.3 | 14.8 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.3 | 4.3 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.2 | 0.7 | GO:0098904 | pulmonary valve formation(GO:0003193) atrial ventricular junction remodeling(GO:0003294) foramen ovale closure(GO:0035922) atrial cardiac muscle cell to AV node cell communication by electrical coupling(GO:0086044) bundle of His cell to Purkinje myocyte communication by electrical coupling(GO:0086054) Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling(GO:0086055) regulation of AV node cell action potential(GO:0098904) regulation of Purkinje myocyte action potential(GO:0098906) vasomotion(GO:1990029) |
0.2 | 6.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 0.6 | GO:0032679 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
0.2 | 9.7 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.2 | 1.9 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.2 | 0.6 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.2 | 3.2 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 0.8 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.1 | 5.6 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.1 | 0.7 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.8 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.1 | 0.5 | GO:0003172 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.1 | 9.4 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
0.1 | 4.3 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.1 | 2.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 3.6 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 3.2 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.7 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 1.7 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.1 | 1.5 | GO:1905145 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 1.8 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 0.4 | GO:0030578 | PML body organization(GO:0030578) |
0.1 | 1.9 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.2 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
0.0 | 3.2 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.0 | 0.3 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 3.2 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 3.3 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.0 | 0.7 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.4 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
0.0 | 4.8 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.0 | 1.9 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.0 | 1.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 3.0 | GO:0042116 | macrophage activation(GO:0042116) |
0.0 | 0.3 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.0 | 0.2 | GO:0072672 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) neutrophil extravasation(GO:0072672) |
0.0 | 0.3 | GO:1902358 | sulfate transmembrane transport(GO:1902358) |
0.0 | 0.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 3.7 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.0 | 0.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 3.1 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.0 | 0.5 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.0 | 8.0 | GO:0030335 | positive regulation of cell migration(GO:0030335) |
0.0 | 0.3 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 3.1 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.0 | 2.2 | GO:0015992 | proton transport(GO:0015992) |
0.0 | 0.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.9 | 5.6 | GO:1990357 | terminal web(GO:1990357) |
0.8 | 12.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.8 | 6.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.8 | 39.1 | GO:0031430 | M band(GO:0031430) |
0.7 | 5.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.6 | 3.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.6 | 2.3 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.5 | 3.2 | GO:0042825 | TAP complex(GO:0042825) |
0.3 | 3.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 0.8 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 2.6 | GO:0005687 | U4 snRNP(GO:0005687) |
0.2 | 9.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 2.2 | GO:0000243 | commitment complex(GO:0000243) |
0.2 | 0.9 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.1 | 3.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 4.1 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 2.0 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 3.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 16.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 3.2 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 5.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.2 | GO:0097679 | other organism cytoplasm(GO:0097679) |
0.1 | 5.8 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.1 | 3.6 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 3.9 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.1 | 8.6 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 35.3 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 4.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.7 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 3.0 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 2.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 5.7 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 1.3 | GO:0030141 | secretory granule(GO:0030141) |
0.0 | 8.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 8.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 5.6 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.3 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 1.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.9 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.0 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 3.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 39.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
2.6 | 10.3 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
1.8 | 8.8 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
1.1 | 5.6 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
1.0 | 3.1 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
0.9 | 7.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.9 | 2.6 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.8 | 9.7 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.7 | 5.9 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) ATP transmembrane transporter activity(GO:0005347) purine nucleotide transmembrane transporter activity(GO:0015216) ADP transmembrane transporter activity(GO:0015217) |
0.7 | 4.8 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.7 | 2.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.6 | 2.5 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.6 | 1.9 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
0.6 | 6.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.5 | 3.2 | GO:0046979 | TAP2 binding(GO:0046979) |
0.5 | 12.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.5 | 4.5 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.4 | 2.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.4 | 4.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.4 | 3.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.3 | 3.1 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 0.9 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.2 | 2.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 1.5 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.2 | 0.7 | GO:0086076 | gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling(GO:0086076) gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling(GO:0086078) gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling(GO:0086079) |
0.2 | 3.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 5.0 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 0.8 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 9.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 3.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 3.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 0.9 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 5.5 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 1.9 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 0.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 4.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 4.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.7 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 3.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 4.3 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 5.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 1.9 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 2.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 3.8 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 1.7 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 4.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.4 | GO:0032810 | sterol response element binding(GO:0032810) |
0.1 | 14.8 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 3.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 5.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 3.0 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 1.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 5.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 4.8 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.3 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.6 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 3.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 2.2 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 3.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 2.0 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.5 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 8.6 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 5.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 2.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.7 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 3.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 2.4 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.3 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 39.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 14.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.3 | 6.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 3.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 6.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 3.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 3.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 5.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 4.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 4.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 6.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 4.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 5.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 3.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 21.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 1.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 3.5 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 1.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 1.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.9 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 39.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.7 | 11.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.6 | 17.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.4 | 9.7 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.4 | 4.1 | REACTOME OPSINS | Genes involved in Opsins |
0.3 | 4.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 4.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.2 | 5.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 3.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 6.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 11.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 9.4 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 1.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 3.0 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 1.9 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 1.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 2.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 2.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 3.5 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 5.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 4.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 5.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 5.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 2.6 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 3.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 4.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 3.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 1.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 3.6 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 3.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 5.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.5 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 3.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |